You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 128 No. 12, December 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  OBSERVATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Q-Switched Ruby Laser Therapy of Nevus of Ota

Roy G. Geronemus, MD

Arch Dermatol. 1992;128(12):1618-1622.


Abstract

• Background.
—The Q-switched ruby laser has been demonstrated to provide selective photothermolysis of pigmented tissue at a wavelength of 694 nm and a pulse width of 40 ns with dermal penetration. It was used to treat 15 patients with nevus of Ota involving the face with an age range of 6 to 52 years. Other methods of treatment for the nevus of Ota have either left scarring or were ineffective. The clinical efficacy of this laser treatment was evaluated in a comparative photographic analysis.

Observations.
—Complete clearing was noted in four of the 15 patients and a minimum of 50% lightening of the original color in the remaining 11. Ten of the 15 patients were Asian, two were white, two were Hispanic, and one was Indian. The energy fluence used varied between 6 and 10 J/cm2, and the number of treatments ranged from 1 to 7. Significant lightening or clearing was found at the higher energy ranges of 9 to 10 J/cm2 with significantly less lightening noted at the lower energy range of 6 to 8.5 J/cm2. No scarring was noted in any of the 15 patients, and some isolated hypopigmentation was noted in one of the subjects. Transient postinflammatory hyperpigmentation of 2 months' duration was noted in only one patient.

Conclusion.
—Q-switched ruby selective photothermolysis appears to be an effective and safe method of lightening or removing nevus of Ota.



Author Affiliations

From the Ronald O. Perelman Department of Dermatology, New York (NY) University School of Medicine.


Footnotes

Accepted for publication September 3, 1992.

Reprint requests to the Department of Dermatology, New York University Medical Center, 530 First Ave, New York, NY 10016 (Dr Geronemus).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Recent developments in lasers and the treatment of birthmarks
Waner
Arch. Dis. Child. 2003;88:372-374.
FULL TEXT  

Dermatologic History of the Ruby Laser: The Long Story of Short Pulses
Anderson
Arch Dermatol 2003;139:70-74.
FULL TEXT  

Laser Treatment of Pigmented Lesions-2000: How Far Have We Gone?
Stratigos et al.
Arch Dermatol 2000;136:915-921.
FULL TEXT  

Long- and Short-term Histological Observations of Congenital Nevi Treated With the Normal-Mode Ruby Laser
Imayama and Ueda
Arch Dermatol 1999;135:1211-1218.
ABSTRACT | FULL TEXT  

Normal-Mode Ruby Laser for Treating Congenital Nevi
Ueda and Imayama
Arch Dermatol 1997;133:355-359.
ABSTRACT  

Treatment of Traumatic Tattoos With the Q-Switched Neodymium:YAG Laser
Suzuki
Arch Dermatol 1996;132:1226-1229.
ABSTRACT  

Treatment of Small and Medium Congenital Nevi With the Q-Switched Ruby Laser
Waldorf et al.
Arch Dermatol 1996;132:301-304.
ABSTRACT  

Treatment of Nevus of Ota with the Q-Switched Ruby Laser
Watanabe and Takahashi
NEJM 1994;331:1745-1750.
ABSTRACT | FULL TEXT  

Lasers in Dermatology--1993
Hruza et al.
Arch Dermatol 1993;129:1026-1035.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.